If you need more lookups,
subscriptions start at $34 USD/month.
Chris Baldwin Location
London, England, GB
Chris Baldwin Work
Vice President, Manufacturing and Supply @ (November 2023 - Present)
Senior Director, Digital Biological Twin Unit Program Lead (Secondment) @ (May 2023 - November 2023)
Senior Director, Cell and Gene Therapy Supply Chain @ (November 2021 - November 2023)
Director, Cell and Gene Therapy Supply Chain (UK based) @ (February 2021 - October 2021)
Director, Cell and Gene Therapy Supply Chain (US based) @ (June 2018 - February 2021)
US Technical Development Leader - Director @ (January 2017 - June 2018)
Medicine and Process Delivery Leader and CMC Leader and Technical Development Leader- Director @ (May 2013 - January 2017)
Medicine and Process Delivery Leader - Manager @ (April 2011 - April 2013)
Principal CMC Regulatory Affairs Executive @ (October 2008 - March 2011)
Team Leader, Manufacturing Development @ (January 2007 - January 2008)
Senior Scientist, Bioprocess R and D @ (January 2004 - January 2007)
Research Fellow @ (January 2002 - January 2004)
Bioprocess scientist (Industrial placement) @ (September 1995 - September 1996)
Chris Baldwin Education
University of Cambridge
PhD (Microbiology)
1998-2002
UCL
MRes (Bioprocessing (Biochemical Engineering))
1997-1998
University of Kent
BSc (Microbiology)
1993-1997
Chris Baldwin Skills
Project Management
Bioprocess
Medicine
Research
Education
Manufacturing
Process Improvement
Customer Service
R&D
Supply Chain Management
Supply Chain
Logistics
Chris Baldwin Summary
Chris Baldwin, based in London, England, GB, is currently a Vice President, Manufacturing and Supply at Resolution Therapeutics. Chris Baldwin brings experience from previous roles at GSK. Chris Baldwin holds a 1998 - 2002 PhD in Microbiology @ University of Cambridge. With a robust skill set that includes Project Management, Bioprocess, Medicine, Research, Education and more. Chris Baldwin has 2 emails on RocketReach.
Looking for a different Chris Baldwin?
Find contact details for 700 million professionals.